June 11th 2025
Compared with penicillin, investigators reported no significant differences in the incidence of ophthalmologic manifestations among patients treated with ceftriaxone.
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
IAPB general assembly set for September
March 21st 2012“Eye Health: Everyone's Business” will be the theme of the ninth general assembly of the International Agency for the Prevention of Blindness, which will be held Sept. 17 to 20 in Hyderabad, India. All ophthalmologists, optometrists, and other eye-care service providers and health-care professionals are invited.
Read More
Game controllers help identify torticollis
March 21st 2012Remotes for the Nintendo Wii gaming system have been known to do everything from sharpen a player’s tennis skills to help rid the world of zombies. So perhaps it’s not surprising that they can also help identify children who have ocular torticollis.
Read More
PBA announces ‘Most Beautiful Eyes’
November 30th 2011Kayla Helferich, 8, from South Carolina, is the grand prize winner in Prevent Blindness America’s (PBA’s) “Most Beautiful Eyes” contest. Helferich has been awarded a $25,000 scholarship and will become the face of Star Pupils, PBA’s signature children's eye health program.
Read More
Bioptigen to study SD-OCT use in infants
October 12th 2011Medical device company Bioptigen Inc. will use a $2.7 million, 27-month grant from the National Eye Institute to study the use of portable spectral-domain optical coherence tomography (SD-OCT) systems in researching, diagnosing, and treating eye diseases in premature and neonatal infants..
Read More
In conjunction with millions of children heading back to school, the new edition of the radio program ?Healthy Vision with Dr. Val Jones? features national experts discussing how early identification of vision problems and vision correction can affect children?s self esteem, confidence, and performance.
Read More
August: Children's eye health month
August 17th 2011With the approach of the school year, Prevent Blindness America (PBA) has declared August as Children's Eye Health and Safety Awareness month, and is encouraging parents to ?make sure every child takes the test that may help them pass all the rest.?
Read More
Bepostastine found to be safe in children, study says
October 15th 2009Twice-daily dosing of bepostastine besilate ophthalmic solution 1.5% was found to be safe, with minimal adverse events, in a randomized, double-masked, 6-week safety study including two groups of healthy pediatric patients.
Read More
Pediatric dispensing for any age
September 15th 2009From babies to toddlers to pre-teens, there are many important considerations to implement when you are dispensing to kids. These considerations range from toddler eyes that are sensitive to ultraviolet rays to protective eyewear for your budding athlete.
Read More
Vision care is lacking for children today
September 1st 2009Healthy vision is vital for success in life and should begin with regular vision screenings during childhood, but the level of inadequate vision care for children in the United States is significant, however. The author addresses ways to address this issue to positively affect high school graduation rates, social and emotional problems, juvenile delinquency, adult literacy problems, incarcerations, and workforce quality and productivity.
Read More
Learning disabilities not caused by vision problems, according to research
July 28th 2009No scientific evidence supports the view that subtle eye or visual problems cause learning disabilities, according to a revised policy statement on learning disabilities, dyslexia, and vision issued by the American Academy of Ophthalmology.
Read More
When amblyopia treatment fails, adherence is likely an issue
November 15th 2008Parents of children with amblyopia may have several reasons (or excuses) for not following a prescribed patching regimen. Ophthalmologists who are following the Pediatric Eye Disease Investigator Group guidelines but are not achieving the desired results, should first examine whether patients are adhering to the prescribed therapy.
Read More
Managing posterior uveitis in children a must
November 15th 2008The adequate management of posterior uveitis in children is difficult but imperative. Many treatment options exist, but to determine the best one for patients, it may be best to divide them into two groups at least initially: those with unilateral disease and those with bilateral disease. Treatment decisions then will follow, based on the severity of the disease.
Read More
Convergence insufficiency therapy responds best to office-based treatment
October 23rd 2008Children with convergence insufficiency improved significantly more with office-based treatment plus home reinforcement compared with home-based or placebo office therapy, according to a study published in the October issue of Archives of Ophthalmology.
Read More